| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/29/2011 | CN102106945A Swelling reliving and tendon and bone-knitting powder |
| 06/29/2011 | CN102106928A Method for preparing high-purity oil tea saponins |
| 06/29/2011 | CN102106918A Method for simultaneously preparing volatile oil, total flavones and total alkaloids from immature bitter oranges |
| 06/29/2011 | CN102106914A Medicament for treating infectious diseases, preparation method and application thereof |
| 06/29/2011 | CN102106907A Quality control method for rhubarb (traditional Chinese medicine) ethanol-extraction process |
| 06/29/2011 | CN102106900A Formula of compound lamiophlomis-root dripping pill |
| 06/29/2011 | CN102106893A Traditional Chinese medicine preparation for relieving pain in myeleterosis |
| 06/29/2011 | CN102106884A Medicinal composition having immunity-regulating function |
| 06/29/2011 | CN102106879A Injection for treating pain diseases of pets and preparation process thereof |
| 06/29/2011 | CN102106854A Application of sinomenine to preparation of analgesic drug |
| 06/29/2011 | CN102106838A Sulfasalazine enteric-coated preparation and preparation method thereof |
| 06/29/2011 | CN102106835A Method for preparing simvastatin tablet by employing micronizing and power direct compressing technologies |
| 06/29/2011 | CN102106823A Resveratrol composite fine particle preparation process applying supercritical fluid crystallization technology |
| 06/29/2011 | CN102106816A Resveratrol nanometer preparation and preparation method thereof |
| 06/29/2011 | CN102106813A Sodium new neohouttuyfonate injection and preparation method and application thereof |
| 06/29/2011 | CN101869692B Curcumin self-microemulsion and preparation method thereof |
| 06/29/2011 | CN101869675B Chinese medicinal composition granules for treating summer-heat damp cold and preparation method thereof |
| 06/29/2011 | CN101744859B Pharmaceutical composition for promoting blood circulation, removing blood stasis and relieving pain and preparation method thereof |
| 06/29/2011 | CN101721674B Traditional Chinese medicine combination for treating gastropathy |
| 06/29/2011 | CN101708265B Rheumatism curing powder |
| 06/29/2011 | CN101708260B Chinese medicinal preparation for treating rheumatic heart valve disease |
| 06/29/2011 | CN101637555B Medicinal liquor soaked with snake |
| 06/29/2011 | CN101627969B Novel curcumin self-emulsifying drug delivery system and preparation method thereof |
| 06/29/2011 | CN101507736B Traditional Chinese medicine preparation for treating senile dementia, ischium lumbar, swollen glands, get-wind or the other rheumatism |
| 06/29/2011 | CN101406581B Ostalgia plaster |
| 06/29/2011 | CN101306181B Elemene fat emulsion injection and preparation method thereof |
| 06/29/2011 | CN101040949B Medicine compound for creating rheumatism and rheumatoid arthritis and the preparing method and application |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968692 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid |
| 06/28/2011 | US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby |
| 06/28/2011 | US7968560 Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968546 Pyridazinone kinase inhibitors |
| 06/28/2011 | US7968545 Compositions useful as inhibitors of voltage-gated ion channels |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968303 Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1) |
| 06/28/2011 | US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 06/28/2011 | CA2635196C Glucocorticoid receptor modulators |
| 06/28/2011 | CA2506603C Nutritional compositions |
| 06/28/2011 | CA2502347C 9a-azalides with anti-inflammatory activity |
| 06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
| 06/28/2011 | CA2465832C Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 06/28/2011 | CA2315976C Serine protease inhibitors |
| 06/23/2011 | WO2011075643A1 Substituted heteroaryl fused derivatives as pi3k inhibitors |
| 06/23/2011 | WO2011075631A1 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1 |
| 06/23/2011 | WO2011075630A1 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
| 06/23/2011 | WO2011075517A1 Aminopyrimidines as syk inhibitors |
| 06/23/2011 | WO2011075515A1 Aminopyrimidines as syk inhibitors |
| 06/23/2011 | WO2011075334A1 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/23/2011 | WO2011074903A2 Pharmaceutical composition containing a3 adenosine receptor agonist |
| 06/23/2011 | WO2011074652A1 Nucleic acid capable of inhibiting expression of hif-2α |
| 06/23/2011 | WO2011074567A1 Transdermal preparation containing basic anti-inflammatory agent |
| 06/23/2011 | WO2011074566A1 Felbinac-containing transdermal absorption preparation |
| 06/23/2011 | WO2011074565A1 Piroxicam-containing endermic preparation |
| 06/23/2011 | WO2011074377A1 Composition containing protopanaxatriol and protopanaxadiol |
| 06/23/2011 | WO2011073961A1 Process for obtaining a standardised extract of quercetin and 3-0-methylquercetin from flowers of macela (achyrocline satureioides), and cosmetic and pharmaceutical compositions comprising said extract |
| 06/23/2011 | WO2011073155A1 Novel antagonists for ccr2 and uses thereof |
| 06/23/2011 | WO2011073154A1 New ccr2 receptor antagonists and uses thereof |
| 06/23/2011 | WO2011073119A1 Mk2 inhibitors |
| 06/23/2011 | WO2011072791A1 Sphingosine kinase inhibitors |
| 06/23/2011 | WO2011072496A1 Epothilone compounds, preparation method and use thereof |
| 06/23/2011 | WO2011012400A3 Nitric oxide releasing naproxen |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110152766 Implant with coating |
| 06/23/2011 | US20110152504 CD16A Binding Proteins and Use for the Treatment of Immune Disorders |
| 06/23/2011 | US20110152361 Novel epigallocatechin gallate tetramer and vascular endothelial function improving agent containing the same |
| 06/23/2011 | US20110152326 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
| 06/23/2011 | US20110152324 Therapeutic agents useful for treating pain |
| 06/23/2011 | US20110152320 Pyrrole derivatives, their preparation and their therapeutic application |
| 06/23/2011 | US20110152318 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
| 06/23/2011 | US20110152307 Ophthalmic composition comprising ascomycin |
| 06/23/2011 | US20110152305 Films and particles |
| 06/23/2011 | US20110152299 Substituted benzamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 06/23/2011 | US20110152296 Heterocyclic compounds and their uses |
| 06/23/2011 | US20110152294 Use of osmolytes obtained from extremophilic bacteria for the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising osmolyte as active agent component |
| 06/23/2011 | US20110152292 Salts comprising a pyrimidinecarboxylic acid derivative for cosmetic use |
| 06/23/2011 | US20110152291 Novel aromatic compounds and their use in medical applications |
| 06/23/2011 | US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 06/23/2011 | US20110152277 Heterocyclic compounds and their uses |
| 06/23/2011 | US20110152276 Substituted pyrrolo[2,3-d]pyrimidines as antifolates |
| 06/23/2011 | US20110152273 Fused heteroaromatic pyrrolidinones |
| 06/23/2011 | US20110152268 Novel pharmaceutical composition for treating nociceptive pain |
| 06/23/2011 | US20110152258 Compounds and Methods for Kinase Modulation, and Indications Therefor |
| 06/23/2011 | US20110152250 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 06/23/2011 | US20110152249 Evaluating central nervous system |
| 06/23/2011 | US20110152244 Pyrrolopyrimidine compounds and their uses |
| 06/23/2011 | US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152240 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors |
| 06/23/2011 | US20110152238 Pharmaceutical compounds |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152235 Aminopyrimidine Kinase Inhibitors |
| 06/23/2011 | US20110152234 Novel Compounds |
| 06/23/2011 | US20110152225 PPAR-Gamma Agonists for the Induction of Cationic Antimicrobial Peptide Expression as Immunoprotective Stimulants |
| 06/23/2011 | US20110152222 Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain |
| 06/23/2011 | US20110152209 Core 2 GlcNAc-T Inhibitors |
| 06/23/2011 | US20110152205 Application of puerarin in the preparation of p2x3 mediated drugs for pain/nervous system diseases |
| 06/23/2011 | US20110152202 Development of c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis |
| 06/23/2011 | US20110152197 Analgesic effects of peptide toxin apetx2 |
| 06/23/2011 | US20110152177 Functional Feed Composition |